## Zhang, Yi

I and my colleagues study biological evolution.  

Euler Technology, Beijing 102206, China, People's Republic of | zy@eulertechnology.com

****

### Education

**Ph.D., Neuroscience**   *Peking University  (2010-2015*)    
**B.Sc., Biological Sciences**  *Peking University  (2006-2010)*    

****

### Selected Publication

- Xiao Y\*, Wang X\*, Weng H\*, Ding Z\*, Qian K\*, Jin W, Lu S, Ju L, He Z, Wang G, Xie X, Liu D, Fan Z, Wu K, Li S, Guo H, Qian G, Jiang W, Leng Y, Zhao J, Cao X, Peng M, Jiang C\#, Li L\#, **Zhang Y**\#, Wang X\#. Ultrasensitive tumour-agnostic non-invasive detection of colorectal cancer recurrence using ctDNA methylation. Clin Transl Med. 2022 Sep;12(9):e1015. 

- Xiao Y\*, Ju L\*, Qian K\*, Jin W\*, Wang G, Zhao Y, Jiang W, Liu N, Wu K, Peng M, Cao R, Li S, Shi H, Gong Y, Zheng H, Liu T, Luo Y, Ma H, Chang L, Li G, Cao X, Tian Y, Xu Z, Yang Z, Shan L, Guo Z, Yao D, Zhou X, Chen X, Guo Z, Liu D, Xu S, Ji C, Yu F, Hong X, Luo J, Cao H, **Zhang Y**\#, Wang X\#. Non-invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study. Clin Transl Med., 2022, 12(8):e1008. 

- Liu W, Shen D, Ju L, Zhang R, Du W, Jin W, Xiong K, Wang G, Qian K, **Zhang Y**\#, Xiao Y\#, Wang X\#. MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3. Oncogene. 2022 Sep 7. doi: 10.1038/s41388-022-02456-x. Epub ahead of print. 

- Xue L\*, He W\*, **Zhang Y**\*, Wang Z, Chen H, Chen Z, Zhu W, Liu D, Jia H, Jiang Y, Wang Z, Wu H. Origins of biallelic inactivation of NF2 in Neurofibromatosis Type 2. *Neuro-Oncology*, 2021, 24 (6), 903-913
 
- Wang Y, Ju L, Guo Z, Qian K, Chen H, **Zhang Y**\#, Xiao Y\#, Wang X\#. Pedigree analysis of a POLD1 germline mutation in urothelial carcinoma shows a close association between different mutation burdens and overall survival. *Cell Mol Immunol.*, 2021, 8(3):767-769.   

- Chen C\*, **Zhang Y**\*, Huang J\*, Yin P\*, Cheng Z, Wu J, Chen S, Zhang Y, Chen B, Lu M, Luo Y, Ju L, Zhang J, Wang X. Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial. Front Pharmacol. 2021 Sep 2;12:683296.

- Qian K\*, Wang G\*, Ju L\*, Liu J, Luo Y, Wang Y, Peng T, Chen F, **Zhang Y**\#, Xiao Y\#, Wang X\#. A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotype. *Oncogene*, 2020, 39(44):6871-6878.   

- Kang L, Liu Y, Jin Y, Li M, Song J, **Zhang Y**, Zhang Y, Yang YL. Mutations of MACF1, Encoding Microtubule-Actin Crosslinking-Factor 1, Cause Spectraplakinopathy. *Frontiers in Neurology*, 2020, 10:1335. 

- Zhang Y\*, **Zhang Y**\*, Zhang VW, Zhang C, Ding H, Yin A. Mutations in both SAMD9 and SLC19A2 genes caused complex phenotypes characterized by recurrent infection, dysphagia and profound deafness - a case report for dual diagnosis. BMC Pediatr. 2019 Oct 21;19(1):364.

- Yu X, Yang L, Li J, Li W, Li D, Wang R, Wu K, Chen W, **Zhang Y**\#, Qiu Z\#, Zhou W\#. De Novo and Inherited SETD1A Variants in Early-onset Epilepsy. *Neuroscience Bulletin*, 2019, 35(6):1045-1057.  

- Wen Z, Cheng TL, Li GZ, Sun SB, Yu SY, **Zhang Y**\#, Du YS\#, Qiu Z\#. Identification of autism-related MECP2 mutations by whole-exome sequencing and functional validation. Mol Autism. 2017 Aug 3;8:43. 

- Wen Z, Cheng TL, Yin DZ, Sun SB, Wang Z, Yu SY, **Zhang Y**\#, Qiu Z\#. Du YS\#. Identification of the Genetic Cause for Childhood Disintegrative Disorder by Whole-Exome Sequencing. *Neuroscience Bulletin*, 2017, 33(2):251-254.  

- Masuyama K, **Zhang Y**, Rao Y, Wang J. Mapping Neural Circuits with Activity-Dependent Nuclear Import of a Transcription Factor. *Journal of Neurogenetics*, 2011, 26(1):89-102.   




